RGC vs. DFDV
RGC (Regencell Bioscience Holdings Limited) and DFDV (DeFi Development Corp) are both stocks. RGC operates in Drug Manufacturers - Specialty & Generic (Healthcare), while DFDV operates in Software - Infrastructure (Technology). Over the past year, RGC returned -53.25% vs -87.54% for DFDV. At a 0.01 correlation, their price movements are largely independent.
Performance
RGC vs. DFDV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RGC achieves a -47.24% return, which is significantly lower than DFDV's -44.36% return.
RGC
- 1D
- 5.42%
- 1M
- -57.05%
- YTD
- -47.24%
- 6M
- -56.12%
- 1Y
- -53.25%
- 3Y*
- -22.17%
- 5Y*
- —
- 10Y*
- —
DFDV
- 1D
- -4.42%
- 1M
- -30.96%
- YTD
- -44.36%
- 6M
- -48.25%
- 1Y
- -87.54%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
RGC vs. DFDV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
RGC Regencell Bioscience Holdings Limited | -47.24% | 325.10% | -52.95% | -43.24% |
DFDV DeFi Development Corp | -44.36% | 700.93% | -41.08% | -74.25% |
Correlation
The correlation between RGC and DFDV is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jul 25, 2023 | 0.01 |
The correlation between RGC and DFDV shifts across timeframes, from 0.01 (all time) to 0.13 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
RGC:
$5.48B
DFDV:
$73.78M
RGC:
-$0.02
DFDV:
-$6.55
RGC:
4.49K
DFDV:
7.24
RGC:
$0.00
DFDV:
$13.76M
RGC:
-$40.84K
DFDV:
$13.42M
RGC:
-$8.81M
DFDV:
-$117.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RGC vs. DFDV — Risk / Return Rank
RGC
DFDV
RGC vs. DFDV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and DeFi Development Corp (DFDV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RGC | DFDV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.41 | ||
| Sortino ratioReturn per unit of downside risk | +2.19 | ||
| Omega ratioGain probability vs. loss probability | 1.08 | 0.85 | +0.23 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | -0.97 | +0.30 |
| Martin ratioReturn relative to average drawdown | -1.26 | -1.25 | -0.01 |
Loading charts...
Drawdowns
RGC vs. DFDV - Drawdown Comparison
The maximum RGC drawdown since its inception was -98.82%, which is greater than DFDV's maximum drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for RGC and DFDV.
Loading charts...
Drawdown Indicators
| RGC | DFDV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.82% | -93.13% | -5.69% |
Max Drawdown (1Y)Largest decline over 1 year | -80.12% | -90.38% | +10.26% |
Max Drawdown (3Y)Largest decline over 3 years | -98.82% | — | — |
Current DrawdownCurrent decline from peak | -98.74% | -92.73% | -6.01% |
Average DrawdownAverage peak-to-trough decline | -64.85% | -73.00% | +8.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 43.23% | 70.23% | -27.00% |
Volatility
RGC vs. DFDV - Volatility Comparison
Regencell Bioscience Holdings Limited (RGC) has a higher volatility of 30.22% compared to DeFi Development Corp (DFDV) at 28.07%. This indicates that RGC's price experiences larger fluctuations and is considered to be riskier than DFDV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RGC | DFDV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 30.22% | 28.07% | +2.15% |
Volatility (6M)Calculated over the trailing 6-month period | 112.48% | 84.54% | +27.94% |
Volatility (1Y)Calculated over the trailing 1-year period | 191.03% | 126.18% | +64.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 283.09% | 515.96% | -232.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 283.09% | 515.96% | -232.87% |
Dividends
RGC vs. DFDV - Dividend Comparison
Neither RGC nor DFDV has paid dividends to shareholders.
Financials
RGC vs. DFDV - Financials Comparison
This section allows you to compare key financial metrics between Regencell Bioscience Holdings Limited and DeFi Development Corp. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RGC and DFDV have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RGC has higher volatility (30.22%) compared to DFDV (28.07%). In terms of maximum drawdown, RGC dropped -98.82% vs DFDV's -93.13%.
RGC currently has the higher Sharpe Ratio (-0.29 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RGC and DFDV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer